These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33443932)

  • 1. Vascular activation is a strong predictor of mortality in coronavirus disease 2019 patients on the ICU.
    De Jongh R; Ninivaggi M; Mesotten D; Bai C; Marcus B; Huskens D; Stragier H; Miszta A; Verbruggen J; de Laat-Kremers RMW; Grieten J; de Laat B
    Blood Coagul Fibrinolysis; 2021 Jun; 32(4):290-293. PubMed ID: 33443932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19.
    Marco A; Marco P
    J Thromb Thrombolysis; 2021 Aug; 52(2):497-503. PubMed ID: 33866481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased von Willebrand factor antigen and low ADAMTS13 activity are related to poor prognosis in covid-19 patients.
    Rodríguez Rodríguez M; Castro Quismondo N; Zafra Torres D; Gil Alos D; Ayala R; Martinez-Lopez J
    Int J Lab Hematol; 2021 Aug; 43(4):O152-O155. PubMed ID: 33502080
    [No Abstract]   [Full Text] [Related]  

  • 4. von Willebrand Factor Multimer Formation Contributes to Immunothrombosis in Coronavirus Disease 2019.
    Doevelaar AAN; Bachmann M; Hölzer B; Seibert FS; Rohn BJ; Bauer F; Witzke O; Dittmer U; Bachmann M; Yilmaz S; Dittmer R; Schneppenheim S; Babel N; Budde U; Westhoff TH
    Crit Care Med; 2021 May; 49(5):e512-e520. PubMed ID: 33591004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obstetric outcomes in pregnant COVID-19 women: the imbalance of von Willebrand factor and ADAMTS13 axis.
    Grandone E; Vimercati A; Sorrentino F; Colaizzo D; Ostuni A; Ceci O; Capozza M; Tiscia G; De Laurenzo A; Mastroianno M; Cappucci F; Fischetti L; Margaglione M; Cicinelli E; Nappi L
    BMC Pregnancy Childbirth; 2022 Feb; 22(1):142. PubMed ID: 35189860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mild deficiency of ADAMTS13 is associated with severity in COVID-19: comparison of the coagulation profile in critically and noncritically ill patients.
    Martín-Rojas RM; Chasco-Ganuza M; Casanova-Prieto S; Delgado-Pinos VE; Pérez-Rus G; Duque-González P; Sancho M; Díez-Martín JL; Pascual-Izquierdo C
    Blood Coagul Fibrinolysis; 2021 Oct; 32(7):458-467. PubMed ID: 34310402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked von Willebrand factor and factor VIII elevations in severe acute respiratory syndrome coronavirus-2-positive, but not severe acute respiratory syndrome coronavirus-2-negative, pneumonia: a case-control study.
    De Cristofaro R; Liuzzo G; Sacco M; Lancellotti S; Pedicino D; Andreotti F
    Blood Coagul Fibrinolysis; 2021 Jun; 32(4):285-289. PubMed ID: 33443926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Willebrand factor/ADAMTS13 axis and venous thromboembolism in moderate-to-severe COVID-19 patients.
    Delrue M; Siguret V; Neuwirth M; Joly B; Beranger N; Sène D; Chousterman BG; Voicu S; Bonnin P; Mégarbane B; Stépanian A
    Br J Haematol; 2021 Mar; 192(6):1097-1100. PubMed ID: 33368196
    [No Abstract]   [Full Text] [Related]  

  • 9. Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS-CoV-2.
    Huisman A; Beun R; Sikma M; Westerink J; Kusadasi N
    Int J Lab Hematol; 2020 Oct; 42(5):e211-e212. PubMed ID: 32441844
    [No Abstract]   [Full Text] [Related]  

  • 10. ICU Admission Levels of Endothelial Biomarkers as Predictors of Mortality in Critically Ill COVID-19 Patients.
    Vassiliou AG; Keskinidou C; Jahaj E; Gallos P; Dimopoulou I; Kotanidou A; Orfanos SE
    Cells; 2021 Jan; 10(1):. PubMed ID: 33477776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective Analyses Associate Hemostasis Activation Biomarkers With Poor Outcomes in Patients With COVID-19.
    Moosavi M; Wooten M; Goodman A; Nahab FB; Duncan A; Maier C; Guarner J
    Am J Clin Pathol; 2021 Mar; 155(4):498-505. PubMed ID: 33300981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Von Willebrand Factor in the Pathogenesis of Pulmonary Vascular Thrombosis in COVID-19.
    Babkina AS; Ostrova IV; Yadgarov MY; Kuzovlev AN; Grechko AV; Volkov AV; Golubev AM
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.
    Takaya H; Namisaki T; Kitade M; Kaji K; Nakanishi K; Tsuji Y; Shimozato N; Moriya K; Seki K; Sawada Y; Saikawa S; Sato S; Kawaratani H; Akahane T; Noguchi R; Matsumoto M; Yoshiji H
    BMC Gastroenterol; 2019 Oct; 19(1):167. PubMed ID: 31638892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIGH HEPARANASE LEVEL IN SURVIVORS OF COVID-19 - INDICATOR OF VASCULAR AND PULMONARY RECOVERY?
    Neb H; Talbot SR; Ruskowski K; Brkic D; Sonntagbauer M; Adam EH; von Knethen A; Zacharowski K; Heinicke U
    Shock; 2022 Dec; 58(6):514-523. PubMed ID: 36548643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activation.
    Ward SE; Curley GF; Lavin M; Fogarty H; Karampini E; McEvoy NL; Clarke J; Boylan M; Alalqam R; Worrall AP; Kelly C; de Barra E; Glavey S; Ni Cheallaigh C; Bergin C; Martin-Loeches I; Townsend L; Mallon PW; O'Sullivan JM; O'Donnell JS;
    Br J Haematol; 2021 Feb; 192(4):714-719. PubMed ID: 33326604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic treatment (argatroban vs. heparin) in coronary angioplasty in angina pectoris: effects on inflammatory, hemostatic, and endothelium-derived parameters.
    Suzuki S; Matsuo T; Kobayashi H; Matsuo M; Shimamo C; Koide M; Sakamoto S
    Thromb Res; 2000 May; 98(4):269-79. PubMed ID: 10822073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe COVID-19 infection associated with endothelial activation.
    Escher R; Breakey N; Lämmle B
    Thromb Res; 2020 Jun; 190():62. PubMed ID: 32305740
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemostasis alterations in sickle cell syndrome].
    Higuera D; Bravo M; Guerrero B
    Invest Clin; 2014 Jun; 55(2):173-84. PubMed ID: 24974633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Von Willebrand Factor, ADAMTS13, and the Risk of Mortality: The Rotterdam Study.
    Sonneveld MA; Franco OH; Ikram MA; Hofman A; Kavousi M; de Maat MP; Leebeek FW
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2446-2451. PubMed ID: 27737864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The features comparison between patients in the ICU and general wards and between patients with different outcomes: a 2020 COVID-19 study.
    Chen Y; Geng Y; Xu X; Chen X; Gao J; Li J; Zhang X
    Ann Palliat Med; 2021 Jan; 10(1):672-680. PubMed ID: 33545796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.